Dimension: Risk factors start consumption
Area
Personal
Specificity
Unspecified: Legal and illegal drugs
Year
2002
Author
Knight, Sherritt, Shrier, Harris, & Chang
Drug use problems
Knight, John
Division of Developmental Medicine, Boston Children’s Hospital
E-mail: john.knigh@tch.harvard.edu
Year
2016
Validation Country
Brazil
Author
Pereira, Schram, & Azevedo
Author Contact Data
Pereira, Bruna
Departamento de Psicologia Médica e Psiquiatria, Faculdade de Ciências Médicas, Universidade Estadual de Campinas. Cidade Universitária Zeferino Vaz, Cidade Universitária. 13081- 970 Campinas SP Brasil
E-mail: bruna.aax.p@gmail.com
References
Pereira, B., Schram, P., & Azevedo, R. (2016). Avaliação da versão brasileira da escala CRAFFT/CESARE para uso de drogas por adolescentes. Ciência & Saúde Coletiva, 21, 91-99.
Year
2017
Validation Country
Spain
Author
Rial, Kim-Harris, Knight, Araujo, Gómez, Braña, Varela, & Golpe
Author Contact Data
Rial, Antonio
Facultad de Psicología, c/ Xosé María Suárez Núñez, s/n. Campus Vida - Universidad de Santiago de Compostela
E-mail: antonio.rial.boubeta@usc.es
References
Rial, A., Kim-Harris, S., Knight, J. R., Araujo, M., Gómez, P., Braña, T., Varela, J., & Golpe, S. (2017) Validación empírica del CRAFFT Abuse Screening Test en una muestra de adolescentes españoles. Adicciones (In press).
CRAFFT assesses drug use among adolescents and their understanding. Includes 10 elements with a dichotomous response (yes / no)
It shows good validity indexes. The test-retest reliability shows temporal stability, and most of the scores values correlate significantly with the clinical classifications. A score of 2 or more was optimal for identifying any problem or disorder and depending on
The criterion to identify drug use problems is a score of 2 or more
Knight, J. R., Sherritt, L., Shrier, L. A., Harris, S. K., & Chang, G. (2002). Validity of the CRAFFT Substance Abuse Screening Test among adolescent clinic patients. Archives of Pediatrics Adolescent Medicine, 156, 607-614.